Board of Directors

Mr. Mark Saldanha is the Chairman and Managing Director of Marksans. Guided by his capable and dynamic leadership, Marksans has experienced rapid growth, achieving new milestones and reaching the pinnacle of performance. He serves as the principal architect, driving the organization's progress and success.

Mr. Mark Saldanha is a science graduate with more than two decades of experience across business and technical functions. He is an integral force in the overall management of the company and possesses a vast amount of hands-on experience in R&D, marketing, production, and finance.

His business acumen, entrepreneurial zeal, organizational skills, and managerial abilities have enabled Marksans to become a global pharmaceutical powerhouse.

Mrs. Sandra Saldanha has a Master’s Degree in Arts (Sociology). She is well-versed in the fields of Human Resource Management, Business Development, Projects and Supply Chain Management. Mrs. Saldanha is also a Director at Marksans Pharma (UK) Limited.

Mr. Varddhman Vikramaditya Jain holds an M. Pharm (Pharmaceuticals) degree and is a seasoned pharmaceutical professional with a robust technical background. With a wealth of experience gained from working with diverse multinational organizations, his expertise spans manufacturing, quality research and development, compliance, and regulatory affairs for both Active Pharmaceutical Ingredients (API) and finished dosage forms.

Over a career spanning 27 years, Mr. Jain has adeptly managed various regulatory inspections, including those by USFDA, MHRA, PMDA Japan, and WHO, showcasing exemplary leadership and profound technical knowledge. His contributions to organizations include the establishment of robust systems capable of withstanding stringent regulatory scrutiny in recent years.

Mr. Seetharama Raju Buddharaju is a Director of the company and has over 36 years of experience in Sales Management, Marketing and Business Administration. He holds a B.Sc., a PGDBM and a PGDMSM. For over 22 years, he has successfully handled various senior sales management roles for Parke-Davis and Pfizer.

Mr. Digant Mahesh Parikh serves as a Director of the company and has over 26 years of experience in Corporate Finance, Strategic Planning, and Business Set up and Scale-up. He holds an MBA in Finance. He is a visiting faculty at leading management schools for the subjects in the field of Corporate & Retail Finance and Banking.

Mr. Abhinna Sundar Mohanty has over 39 years of experience in the pharmaceutical industry. He started his career with Alembic and went on to build his career through every cadre in the sales and marketing department of the pharma industry. During his career, he was engaged in sales, marketing, business development, and business strategy. He was instrumental in globalising branded business for the pharma sector globally. He has completed an M.Sc. in Mathematics.

Dr. Sunny Sharma is a Senior Managing Director of OrbiMed Asia. Previously, he was with Investor Growth Capital (IGC), the investment arm of Investor AB in North America, and before that with Easton Capital in New York. Earlier in his career, Dr. Sharma worked in the healthcare investment banking group of Lehman Brothers in London. He holds an MBA and MBBS.

Mrs. Shailaja Vardhan, a seasoned professional in communications, boasts an impressive track record spanning over three decades. Over the course of her career, she has played pivotal roles in both multinational corporations and entrepreneurial ventures, demonstrating expertise in developing brand architecture, devising positioning strategies, formulating go-to-market approaches, and implementing impactful communication initiatives to elevate brand reputation.

Recognized as one of India's premier corporate communications professionals, her wealth of experience has contributed significantly to her acclaim. Currently, Shailaja Vardhan plays a pivotal role in steering leadership communication at the Apollo Hospitals Group, serving as a driving force behind its strategic communications initiatives.